Dihydromyricetin protects against cisplatin-induced renal injury and mitochondria-mediated apoptosis via the EGFR/HSP27/STAT3 signaling pathway.
Saved in:
| Title: | Dihydromyricetin protects against cisplatin-induced renal injury and mitochondria-mediated apoptosis via the EGFR/HSP27/STAT3 signaling pathway. |
|---|---|
| Authors: | Xu, Zheming1,2 (AUTHOR), Zhang, Minjing1,2 (AUTHOR), Zhang, Xue1,2 (AUTHOR), Han, Huirong3 (AUTHOR), Ye, Weifeng2 (AUTHOR), Chen, Zhenjie2 (AUTHOR), Lv, Zhisu2 (AUTHOR), Liu, Yang2 (AUTHOR), Liu, Zhengye4 (AUTHOR), Gong, Jianguang5 (AUTHOR), Zhu, Bin5 (AUTHOR), Zhou, Suhan6 (AUTHOR), Zhu, Runzhi2 (AUTHOR), Tao, Chang1,2 (AUTHOR), Zhang, Gensheng1,2 (AUTHOR) 20919060@zju.edu.cn, Yan, Xiang1,2 (AUTHOR) yanxiang@zju.edu.cn |
| Source: | Renal Failure. Dec2025, Vol. 47 Issue 1, p1-16. 16p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!